Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor, Adult|Epithelial Ovarian Cancer|Small Cell Lung Carcinoma|Breast Cancer|Colorectal Cancer|Pancreas Cancer|Appendix Cancer|Non-small Cell Lung Cancer|Gastric Cancer|Esophagus Cancer|Urothelial Carcinoma|Sarcoma
Interventions: DRUG: CBX-12
Sponsor: Cybrexa Therapeutics